Pay in 4 interest-free payments of $6.42 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
About a year later, the University of Tokushima in Japan, in collaboration with Eisai, launched a Phase 3 trial called JETALS (NCT03548311) to confirm the results of the prior analyses
Most people report improvement in fatigue and anemia symptoms within 2472 hours after the first injection, especially with severe deficiency
Heaters: Mats run in a very safe zone of 0.2-0.8 milligauss
Patients often report improved focus, enhanced mood, and greater stamina after treatment
Subcutaneous injections deliver medication into the layer of tissue just below the skin, while intramuscular injections go one layer deeper, directly into the muscle
Do not increase the amount or frequency because a vial appears to contain more than one possible dose
